Literature DB >> 8572144

Pediatric sensorineural hearing loss after temporal bone radiation.

R S Fong1, D J Beste, K J Murray.   

Abstract

In adults, sensorineural hearing loss (SNHL) resulting from megavoltage temporal bone radiation therapy (RT) is dose dependent. A review of the literature reveals only two cases of pediatric SNHL after RT without chemotherapy. This report presents four cases of late onset, asymmetric SNHL after RT in children treated for posterior fossa tumors. The children were treated with surgical resection of the tumor, followed by RT of 50 to 54 gray and no chemotherapy. These children, without evidence of tumor recurrence, developed severe SNHL 18 to 36 months after the completion of RT. Although no definite audiometric pattern was seen, most of the patients had a predominately high frequency SNHL in the poorer hearing ear, and fluctuant hearing in the better ear, without evidence of osteoradionecrosis or otitic infection. A review of the literature suggests that injury to the outer hair cells and cochlear neurons of the basal turn of the cochlea are possible sources for the hearing loss. Pretreatment audiologic evaluation as well as a minimum of 3 years of evaluations following RT would be prudent.

Entities:  

Mesh:

Year:  1995        PMID: 8572144

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  8 in total

Review 1.  Evaluation and Management of Hearing Loss in Survivors of Childhood and Adolescent Cancers: A Report From the Children's Oncology Group.

Authors:  Johnnie K Bass; Kristin R Knight; Torunn I Yock; Kay W Chang; Douglas Cipkala; Satkiran S Grewal
Journal:  Pediatr Blood Cancer       Date:  2016-02-29       Impact factor: 3.167

Review 2.  Proton beam therapy following resection for childhood ependymoma.

Authors:  Shannon M MacDonald; Torunn I Yock
Journal:  Childs Nerv Syst       Date:  2009-12-19       Impact factor: 1.475

3.  The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancer.

Authors:  J J Yang; J Y S Lim; J Huang; J Bass; J Wu; C Wang; J Fang; E Stewart; E H Harstead; S E; G W Robinson; W E Evans; A Pappo; J Zuo; M V Relling; A Onar-Thomas; A Gajjar; C F Stewart
Journal:  Clin Pharmacol Ther       Date:  2013-06-11       Impact factor: 6.875

Review 4.  Auditory late effects of childhood cancer therapy: a report from the Children's Oncology Group.

Authors:  Satkiran Grewal; Thomas Merchant; Renee Reymond; Maryrose McInerney; Cathy Hodge; Patricia Shearer
Journal:  Pediatrics       Date:  2010-03-01       Impact factor: 7.124

5.  Hearing Loss in Patients Who Received Cranial Radiation Therapy for Childhood Cancer.

Authors:  Johnnie K Bass; Chia-Ho Hua; Jie Huang; Arzu Onar-Thomas; Kirsten K Ness; Skye Jones; Stephanie White; Shaum P Bhagat; Kay W Chang; Thomas E Merchant
Journal:  J Clin Oncol       Date:  2016-01-25       Impact factor: 44.544

6.  Current treatment options for pediatric and adult patients with ependymoma.

Authors:  Karen D Wright; Amar Gajjar
Journal:  Curr Treat Options Oncol       Date:  2012-12

7.  Highly Conformal Craniospinal Radiotherapy Techniques Can Underdose the Cranial Clinical Target Volume if Leptomeningeal Extension through Skull Base Exit Foramina is not Contoured.

Authors:  D J Noble; T Ajithkumar; J Lambert; I Gleeson; M V Williams; S J Jefferies
Journal:  Clin Oncol (R Coll Radiol)       Date:  2017-03-18       Impact factor: 4.126

8.  A unique radioprotective effect of resolvin E1 reduces irradiation-induced damage to the inner ear by inhibiting the inflammatory response.

Authors:  Jie Zhang; Anting Xu; Tingting Niu; Chengcheng Liu; Yongju Zhang; Tao Li; Jihua Wang; Yongjing Wang; Dianshui Sun
Journal:  Radiat Oncol       Date:  2020-09-25       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.